Comprehensive mass spectrometry based biomarker discovery and validation platform as applied to diabetic kidney disease

A protein biomarker discovery workflow was applied to plasma samples from patients at different stages of diabetic kidney disease. The proteomics platform produced a panel of significant plasma biomarkers that were statistically scrutinised against the current gold standard tests on an analysis of 5...

Descripción completa

Detalles Bibliográficos
Autores principales: Bringans, Scott D., Ito, Jun, Stoll, Thomas, Winfield, Kaye, Phillips, Michael, Peters, Kirsten, Davis, Wendy A., Davis, Timothy M.E., Lipscombe, Richard J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5988498/
https://www.ncbi.nlm.nih.gov/pubmed/29900119
http://dx.doi.org/10.1016/j.euprot.2016.12.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5988498/
https://www.ncbi.nlm.nih.gov/pubmed/29900119
http://dx.doi.org/10.1016/j.euprot.2016.12.001

Ejemplares similares